VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
Coloplast A/S vs DexCom, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Coloplast A/S
COLOB · Nasdaq Copenhagen
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Coloplast A/S's moat claims, evidence, and risks.
View COLOB analysisDexCom, Inc.
DXCM · Nasdaq Global Select Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into DexCom, Inc.'s moat claims, evidence, and risks.
View DXCM analysisComparison highlights
- Moat score gap: DexCom, Inc. leads (82 / 100 vs 77 / 100 for Coloplast A/S).
- Segment focus: Coloplast A/S has 5 segments (35.5% in Ostomy Care); DexCom, Inc. has 1 segment (100% in Continuous glucose monitoring systems).
- Moat breadth: Coloplast A/S has 7 moat types across 3 domains; DexCom, Inc. has 5 across 3.
Primary market context
Coloplast A/S
Ostomy Care
Ostomy care products (bags, plates, supporting products)
Global
Healthcare providers and distributors; end-users are ostomy patients
Medical device manufacturer (disposable consumables)
35.5%
DexCom, Inc.
Continuous glucose monitoring systems
Global continuous glucose monitoring systems and glucose biosensing devices
Global, with FY2025 revenue 71.5% United States and 28.5% international
People with diabetes, metabolic-health users, caregivers, clinicians, payors, distributors and pharmacy channels
CGM device manufacturer, disposable sensor supplier, software/data platform and distribution partner
100%
Side-by-side metrics
Moat coverage
Shared moat types
Coloplast A/S strengths
DexCom, Inc. strengths
Segment mix
Coloplast A/S segments
Full profile >Ostomy Care
Oligopoly
Continence Care
Oligopoly
Voice & Respiratory Care
Oligopoly
Wound & Tissue Repair
Competitive
Interventional Urology
Oligopoly
DexCom, Inc. segments
Full profile >Continuous glucose monitoring systems
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.